Published in TB and Outbreaks Week, February 14th, 2006
Study 1: The Bayer TruGene genotype assay detects and characterizes non-subtype-B HIV-1 strains.
"Human immunodeficiency virus type I (HIV-1) protease (PR) and reverse transcriptase (RT) gene sequences obtained during antiretroviral resistance testing with a commercial genotyping assay (TruGene; Bayer Corp.) were analyzed to assess the utility of these data for detecting and characterizing non-subtype-B HIV-1 strains.
"A total of 125 viral sequences obtained from patients believed to have acquired their HIV-1 infection in Africa were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.